Skip to main content
866-667-0720 [email protected] Hands-on CME training for licensed medical professionals
CME-accredited workshop

Pain Management Training

Trigger-point injection, joint injection (knee, shoulder, hip), bursa work, and an introduction to ultrasound-guided technique — taught by practicing pain physicians.

Practicing physician faculty Live patients on training day AMA PRA Category 1 Credit™
About this program

What this workshop covers

The decision to inject a joint or soft-tissue structure begins with a clear assessment of the patient's overall health, pain pattern, and functional goals. A thorough history should identify prior surgeries, anticoagulant use, infection risk, and systemic conditions that may alter the safety profile of an injection. Clinicians must weigh the expected benefit against potential adverse effects, recognizing that not every painful joint requires a procedural intervention. This judgement call is the foundation for all subsequent steps.

Physical examination follows the history and focuses on alignment, range of motion, and specific provocative maneuvers that localize the source of pain. Identifying signs such as swelling, warmth, or neurovascular compromise alerts the provider to possible infection, inflammatory arthritis, or structural damage that may contraindicate injection. For soft-tissue targets, palpation of the tendon sheath or bursa guides needle placement, while joint injections require assessment of capsular tightness and effusion. These findings shape the choice of approach and help determine whether a procedural attempt is appropriate.

Injection technique varies by site, but core principles remain constant. Sterile gloves, a skin antiseptic, and a sterile field reduce infection risk, and the needle trajectory should avoid neurovascular structures identified during the exam. For intra-articular injections, a short-bevel needle is often preferred, while longer needles may be required for deep bursae. Selecting a corticosteroid involves considering solubility, duration of action, and the joint's capacity to tolerate volume. Dosing intervals are guided by the drug's pharmacokinetics and the patient's prior response, typically ranging from weeks to months.

Ultrasound guidance adds real-time visualization of anatomy, allowing the clinician to confirm needle tip placement and avoid structures that are not palpable. This technology can change the decision to proceed when anatomic variations or calcifications are present, and it often improves accuracy for small joints and deep soft-tissue targets. However, ultrasound does not replace the need for clinical judgment; providers must still decide whether imaging, such as MRI or CT, or a specialist referral is required before attempting a procedure, especially when the diagnosis is uncertain or when surgical options may be more appropriate.

Documentation completes the clinical loop by recording the indication, patient selection criteria, physical findings, imaging review, and the procedural details including needle size, medication, and volume. Noting any immediate complications and the patient's response provides a reference for future care and supports medicolegal protection. Clear entries also facilitate communication with other members of the care team, ensuring that follow-up plans and any needed referrals are evident. By integrating thorough documentation with each judgement call, clinicians create a reliable record that underpins safe and effective pain management.

What you'll be able to do after this workshop

  • Identify appropriate candidates for joint and soft-tissue injections
  • Perform a focused musculoskeletal exam to detect red-flag findings
  • Choose injection sites and needle trajectories for common joints
  • Apply sterile technique to minimize infection risk
  • Select corticosteroid type and dosing interval based on evidence
  • Integrate ultrasound guidance to improve accuracy and safety
  • Determine when imaging or specialist referral is required before injection
  • Document procedural decision-making and outcomes comprehensively

At a glance

Format
In-person, hands-on
Cohort size
~12 attendees, supervised
Who attends
MD, DO, NP, PA. Particularly relevant for primary care, family medicine, and sports medicine.
Credit
AMA PRA Category 1™
View Dates
Upcoming sessions

Next cohorts for Pain Management Training (The Pain Show)

Pulled live from the MD Education calendar. Click any date to see the venue, agenda, and registration.

Saturday, September 19, 2026
Dallas, TX
Saturday, November 7, 2026
Orlando, FL
Saturday, January 23, 2027
Los Angeles, CA
Saturday, February 20, 2027
Newark, NJ
Saturday, February 20, 2027
Orlando, FL
Saturday, March 13, 2027
Las Vegas, NV
Saturday, June 5, 2027
Long Island, NY
Ready to register?

Talk to an MD Education advisor

Tell us a bit about your goals and we'll match you to the right cohort, share pricing, and walk you through payment plans.

Get info on Pain Management Training (The Pain Show)

Tell us a bit about you and an MD Education advisor will reach out with pricing, dates, and cohort availability.

Frequently asked

FAQ for Pain Management Training (The Pain Show)

How do I decide if a patient is a good candidate for an intra-articular steroid injection?

Begin with a detailed history that clarifies the pain duration, functional limitation, and prior treatments. Confirm that the joint is the primary pain generator by correlating symptoms with physical findings. Exclude active infection, uncontrolled diabetes, or recent joint surgery that would increase risk. Consider the patient's overall health, anticoagulant status, and ability to adhere to post-procedure instructions. If the expected benefit, such as temporary pain relief or improved range of motion, outweighs the potential adverse effects, the patient may be a suitable candidate. Document the rationale for the decision in the medical record.

What physical exam findings should prompt me to avoid an injection and consider alternative management?

Findings that raise concern include marked swelling, warmth, or erythema suggesting infection; severe neurovascular compromise such as loss of sensation or pulses; gross instability that may require surgical stabilization; and signs of advanced osteoarthritis where structural damage limits the benefit of a steroid. Additionally, a positive joint line tenderness with limited passive motion may indicate a fracture or severe inflammatory process. When any of these red-flag signs are present, defer the injection, obtain appropriate imaging, and refer the patient for further evaluation before proceeding.

When is ultrasound guidance essential versus using anatomic landmarks alone?

Ultrasound becomes essential when the target structure is deep, small, or obscured by overlying tissue, such as the hip joint, sacroiliac joint, or small bursae. It is also valuable when anatomic variations, calcifications, or prior surgery may alter normal landmarks. In cases where the practitioner has limited experience with a particular site, ultrasound can confirm needle trajectory and reduce the risk of neurovascular injury. For larger, superficial joints with well-defined landmarks, such as the knee or shoulder, an experienced clinician may safely use a landmark-based approach, but ultrasound still offers a safety net if uncertainty exists.

What are the key steps in maintaining sterility during a joint injection?

First, perform hand hygiene and wear sterile gloves. Prepare the skin with an appropriate antiseptic, allowing the recommended contact time before proceeding. Use a sterile drape or large gauze to create a clean field around the injection site. Keep all equipment, including syringes, needles, and medication vials, within the sterile field and avoid touching non-sterile surfaces. After needle insertion, maintain sterility of the needle hub and syringe until the medication is delivered. Finally, apply a sterile dressing if indicated and dispose of all sharps according to institutional protocols.

How do I choose the appropriate corticosteroid formulation and dosing interval for different joints?

Select a formulation based on solubility and desired duration of action. For large joints such as the knee or hip, a particulate steroid (e.g., methylprednisolone acetate) provides longer relief, while a less particulate agent (e.g., dexamethasone) may be preferred for smaller joints to reduce the risk of crystal deposition. Dose the steroid according to joint capacity; typically, 0.5 mL to 1 mL of a 40 mg/mL solution for the knee, less for smaller joints. Interval between injections should respect the drug's half-life and the patient's prior response, generally no more frequently than every 3 to 4 months to avoid cartilage toxicity.

What factors determine whether I am allowed to perform a joint injection in my practice?

The ability to perform injections is defined by the clinician's licensure, the scope of practice set by the governing licensing board, and any institutional policies that apply. Each board outlines which procedures are permissible for physicians, nurse practitioners, physician assistants, and registered nurses, often requiring documented training or supervision. In addition, malpractice coverage and credentialing committees may have specific requirements. Before offering injections, verify that your professional credentials, board-defined scope, and local practice policies all align with the intended procedure.

What does hands-on practice provide that a video demonstration cannot?

Hands-on practice allows the learner to develop tactile feedback, needle control, and spatial awareness that are difficult to convey through video alone. Feeling tissue resistance, confirming needle tip placement by palpation, and adjusting angle in real time build muscle memory essential for safe injections. Direct supervision also enables immediate correction of technique, reinforcement of sterile field management, and personalized guidance on handling unexpected patient responses. While video can illustrate steps, only live practice under expert observation ensures competence and confidence before independent clinical use.

Related training

If you're learning Pain Management Training (The Pain Show), also explore

Sponsored by

Brought to you in partnership with industry leaders

Empire Medical Training
Premier sponsor
Empire Medical Training
25+ years training physicians, NPs, PAs and RNs in aesthetic & regenerative medicine.
Visit Empire Medical Training